Products for HIV Protease
- Cat.No. Product Name Information
-
BCC1921
Saquinavir
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
-
BCC1922
Saquinavir mesylate
Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy.
-
BCC3620
Ritonavir
Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS.
-
BCC1794
Nelfinavir Mesylate
Nelfinavir Mesylate (AG 1343 Mesylate) is a potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) and antiviral agent for the treatment of HIV infection. Nelfinavir Mesylate (AG 1343 Mesylate) is a broad-spectrum, anticancer agent.
-
BCC3619
Amprenavir (agenerase)
Amprenavir (VX-478) is a HIV protease inhibitor(Ki=0.6 nM) used to treat HIV infection.
-
BCC2002
Tipranavir
Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM.
-
BCC3621
Lopinavir
Lopinavir is a potent HIV protease inhibitor with Ki of 1.3 pM.
-
BCC3623
Darunavir
Darunavir(TMC114) is an HIV protease inhibitor.
-
BCC1581
Fosamprenavir Calcium Salt
Fosamprenavir Calcium Salt (GW433908G) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility. Anti-HIV infection.
-
BCC2114
Atazanavir sulfate (BMS-232632-05)
Atazanavir sulfate (BMS-232632 sulfate) is a highly selective HIV-1 protease inhibitor for the treatment of HIV infection, and is the first protease inhibitor approved for once-daily administration. Atazanavir sulfate (BMS-232632 sulfate) is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp).
-
BCC5627
Darunavir Ethanolate
Darunavir ethanolate (TMC114 Ethanolate) is a potent HIV protease inhibitor used to treat and prevent HIV/AIDS. Darunavir has a Ki of 1 nM for wild type HIV-1 protease.
-
BCC1427
BMS-626529
Temsavir (BMS-626529) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.
-
BCC1619
HIV-1 integrase inhibitor 2
HIV-1 integrase inhibitor 2, in the treatment of human immunodeficiency virus (HIV) infection.
